Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 29,250
+50 (0.17%)
At close: Aug 14, 2025, 3:30 PM KST
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 1.48 trillion as of August 15, 2025. Its market cap has decreased by -20.01% in one year.
Market Cap
1.48T
Enterprise Value
1.47T
Revenue
141.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
29,250.00
Market Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 1.48T, an increase of 5,543.29%. That is a compound annual growth rate of 14.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 1,484.15B | -24.28% |
| Dec 30, 2024 | 1,959.95B | -12.72% |
| Dec 28, 2023 | 2,245.71B | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1,077.89B | -43.84% |
| Dec 30, 2020 | 1,919.22B | 3.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.58T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,561.74B |
| Peptron | 8,235.61B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 7,106.52B |
| LigaChem Biosciences | 5,666.20B |